Author

Anjali A. Advani

Cleveland ClinicORCID 0000-0003-0015-5902Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. J. MurisoniD· 1 shared Airen Zaldívar PerazaiD· 1 shared Andy G.X. ZengiD· 1 shared Carla GrandoriiD· 1 shared Cecilia C.S. YeungiD· 1 shared Charles Grenfell MullighaniD· 1 shared Cheng ChengiD· 1 shared Chunxu QuiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. J. MurisonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyBiomolecules and BiomedicinePeer-reviewedOct 28, 2026

Efficacy evaluation of glasedgib Sonic Hedgehog pathway inhibition with or without inotuzumab in B-ALL cells using a new co-culturing system model and a validated chemosensitivity assay

David W. Woolston, Michael Churchill, Carla Grandori…·Cecilia C.S. Yeung

This study evaluates the efficacy of glasdegib and its combination with inotuzumab on B-ALL cells using a co-culturing system and chemosensitivity assay, showing varying responses based on SHH gene expression.

DOI 10.17305/bb.2026.14405

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyNature CancerPeer-reviewedJun 27, 2025

Single cell dissection of developmental origins and transcriptional heterogeneity in B-cell acute lymphoblastic leukemia

Ilaria Iacobucci, Andy G.X. Zeng, Qingsong Gao…·Charles Grenfell Mullighan

This study uses scRNA-seq to analyze B-ALL samples, revealing transcriptional heterogeneity and developmental origins, with specific subtypes associated with distinct cell populations and clinical outcomes.

53 citationstop 1%

humanscRNA-seq

𝕏 PostBluesky